Necrotizing Soft Tissue Infection: Clinical Trials

2 trials for Necrotizing Soft Tissue Infection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated. 2 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Terminated 1
Phase 11Terminated 1

Follow Necrotizing Soft Tissue Infection: new trials by email Literature Review of Necrotizing Soft Tissue Infection trials Research Report on Necrotizing Soft Tissue Infection

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
HAT for the Treatment of Sepsis Associated With NASTI
HAT, Placebo - Necrotizing Soft Tissue Infection, Sepsis
Phase 1 / Phase 2TerminatedAscension Health102021-09-102024-07-24
Immunoglobulin for Necrotizing Soft Tissue Infections: a Randomised Controlled Trial
IVIG (Privigen), Saline 0.9% - Necrotizing Soft Tissue Infection, Necrotizing Fasciitis
Phase 2CompletedAnders Perner1002014-04-012016-09-30

Narrower conditions

Fasciitis, Necrotizing (1)  ·  Fournier Gangrene (1)  ·  Gas Gangrene (1)  ·  Sepsis (1)

Broader conditions

Infections (2)  ·  Bacterial Infections (1)  ·  Bacterial Infections and Mycoses (1)  ·  Clostridium Infections (1)  ·  Fasciitis (1)  ·  Genital Diseases (1)  ·  Genital Diseases, Male (1)  ·  Gram-Positive Bacterial Infections (1)  ·  Inflammation (1)  ·  Male Urogenital Diseases (1)  ·  Musculoskeletal Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Systemic Inflammatory Response Syndrome (1)  ·  Urogenital Diseases (1)

Interventions

Sodium Chloride (2)  ·  Ascorbic Acid (1)  ·  Hydrocortisone (1)  ·  Immunoglobulin G (1)  ·  Immunoglobulins, Intravenous (1)  ·  Thiamine (1)

Sponsors

Anders Perner (1)  ·  Ascension Health (1)

Countries

Denmark (1)  ·  United States (1)

Top investigators

Anders Perner, Professor (1)  ·  Thomas Resch, M.D. (1)

Results publications

PMID 27399982, PMID 28421246, PMID 31916575